Cognitive therapy for unipolar depression: effect of a dilemma-focused interventio
- Conditions
- Major Depressive Disorder, dysthymic disorder.Mental and Behavioural DisordersDysthymia, recurrent depressive disorder, unspecified
- Registration Number
- ISRCTN92443999
- Lead Sponsor
- niversity of Barcelona (Spain)
- Brief Summary
1. 2013 protocol in: http://www.ncbi.nlm.nih.gov/pubmed/23683841 (added 25/10/2013) 2. 2016 results in: https://www.ncbi.nlm.nih.gov/pubmed/27103215 (added 16/04/2019) 3. 2017 results in: https://www.ncbi.nlm.nih.gov/pubmed/26367519 (added 16/04/2019) 4. 2018 results in: https://www.ncbi.nlm.nih.gov/pubmed/30543642 (added 16/04/2019)
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 128
1. Aged 18 to 70 years old
2. Both genders
3. Meeting diagnostic criteria for Major Depressive Disorder (MDD) or Dysthymic Disorder (DD) according to the DSM-IV-TR (APA, 2002) criteria assessed using SCID-I
4. A score above 19 on the BDI-II Questionnaire
5. Presenting at least one cognitive conflict (implicative dilemma or dilemmatic construct) as assessed using the Repertory Grid Technique
6. Enough level of competence to communicate in Spanish or Catalan
1. Bipolar disorders
2. Psychotic symptoms
3. Substance abuse
4. Organic brain dysfunction
5. Mental retardation
6. Serious suicidal ideation
7. Receiving psychological treatment (unless it is suspended at the time of inclusion in the study itself, in agreement with the patient and the practitioner applying it)
8. Substantial visual, hearing or cognitive deficits
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change from baseline in Beck Depression Inventory-Second Edition (BDI-II) at the end of therapy.
- Secondary Outcome Measures
Name Time Method <br> 1. Change from baseline in Clinical Outcomes in Routine Evaluation - Outcome Measure (CORE-OM) at the end of therapy<br> 2. Change from baseline in Hamilton Anxiety Rating Scale (HARS) at the end of therapy<br> 3. Change from baseline in measures of the Repertory Grid Technique<br>